Clinical Trial Update: Pivotal Trial for a Synthetic Tissue Substitute for Concealment of Artificial Ocular Implants [NA]

View source ↗

Summary

The pivotal trial evaluating CorNeat Vision Ltd.'s synthetic tissue substitute for concealing artificial ocular implants has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Synthetic Tissue Substitute for Concealment of Artificial Ocular Implants

Snippet

Sponsor: CorNeat Vision Ltd. | Conditions: Glaucoma Eye, Tissue Breakdown | NA | Status: TERMINATED